{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05739162",
            "orgStudyIdInfo": {
                "id": "22-007643"
            },
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis",
            "officialTitle": "Endoscopic Sleeve Gastroplasty (ESG) as a Treatment Option for Obesity in Ulcerative Colitis (UC) Patients Undergoing Colectomy With Ileal Pouch Anal Anastomosis (IPAA)",
            "therapeuticArea": [
                "Endocrinology",
                "Gastroenterology"
            ],
            "study": "a-study-of-endoscopic-sleeve-gastroplasty-for-obesity-in-ulcerative-colitis"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-09-20",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-02-13",
            "studyFirstSubmitQcDate": "2023-02-13",
            "studyFirstPostDateStruct": {
                "date": "2023-02-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-10-18",
            "lastUpdatePostDateStruct": {
                "date": "2023-10-19",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Amanda M. Johnson",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Mayo Clinic"
            },
            "leadSponsor": {
                "name": "Mayo Clinic",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this research is to gather information on the safety and effectiveness of Endoscopic Sleeve Gastroplasty (ESG) for weight loss in a population of obese ulcerative colitis (UC) patients undergoing colectomy with eventual Ileal Pouch Anal Anastomosis (IPAA) compared to counseling on diet and lifestyle interventions alone."
        },
        "conditionsModule": {
            "conditions": [
                "Obesity",
                "Ulcerative Colitis"
            ],
            "keywords": [
                "ESG",
                "IPAA"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 24,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Endoscopic Sleeve Gastroplasty (ESG)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants undergo Endoscopic Sleeve Gastroplasty (ESG). Following the 6-week transitional diet after undergoing the ESG procedure, participants will start the lifestyle intervention.",
                    "interventionNames": [
                        "Device: Apollo Endoscopic Suture System",
                        "Behavioral: Lifestyle Intervention"
                    ]
                },
                {
                    "label": "Diet and Exercise",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants receive lifestyle intervention only for 24 months",
                    "interventionNames": [
                        "Behavioral: Lifestyle Intervention"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Apollo Endoscopic Suture System",
                    "description": "Endoscopic Sleeve Gastroplasty (ESG), and endoscopic minimally-invasive weight loss procedure, utilizing a suturing device to reduce the stomach volume by 70-80% through the creation of sleeve. This is accomplished by a series of endoscopically placed stitches through the stomach wall.",
                    "armGroupLabels": [
                        "Endoscopic Sleeve Gastroplasty (ESG)"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Lifestyle Intervention",
                    "description": "Low-calorie healthy diet personalized by a dietician according to individual patients' needs and conducive to weight loss. Physical activity will be encourage and assessed.",
                    "armGroupLabels": [
                        "Diet and Exercise",
                        "Endoscopic Sleeve Gastroplasty (ESG)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percent total body weight loss",
                    "description": "Percent total body weight loss (%TBWL) calculated by the equation ((visit 3 weight in kilograms (kg) subtracted by randomization weight in kg) divided by randomization weight in kg) times 100.",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Number of subjects with serious adverse events",
                    "description": "Total number of subjects to report serious adverse event related to the ESG procedure",
                    "timeFrame": "24 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Number of early peri-operative complications",
                    "description": "Number of early (less than 30 days) peri-operative complications related to IPAA and ileostomy takedown clinical standard of care procedure",
                    "timeFrame": "1 year following procedure"
                },
                {
                    "measure": "Number of late peri-operative complications",
                    "description": "Number of late (greater than 30 days) peri-operative complications related to IPAA and ileostomy takedown clinical standard of care procedure",
                    "timeFrame": "1 year following procedure"
                },
                {
                    "measure": "Change gastrointestinal symptom rating scale (GSRS)",
                    "description": "ESG tolerance measured by GSRS which includes 15 items and utilizes a 7-point response scale to measure a participant's level of discomfort associated with a given GI symptom, ranging from \"No discomfort at all\" to \"Very severe discomfort.\"",
                    "timeFrame": "Week 4, Week 12, Week 24, 12 months post-ileostomy takedown"
                },
                {
                    "measure": "Pouchitis disease activity index (PDAI)",
                    "description": "Assess overall pouch function one year following ileostomy takedown using the pouchitis disease activity index (PDAI) score. The PDAI quantitates clinical symptoms and endoscopic and histological features (acute histological inflammation: crypt abscess and ulceration) on three separate six-point scores, whereby a total score higher than 7 is indicative of pouchitis.",
                    "timeFrame": "12 months post-ileostomy takedown"
                },
                {
                    "measure": "Durable weight loss",
                    "description": "Number of subjects to achieve durable weight loss",
                    "timeFrame": "12 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* BMI 30-50 kg/m2 for at least 6 months prior to ESG\n* Diagnosis of UC with plans to undergo or who have already undergone colectomy as part of a plan to pursue eventual 3-stage ileal pouch anal anastomosis (IPAA)\n* Willing to adhere to the diet and behavior modifications required for ESG\n* Able to follow the visit schedule\n* Able to provide informed consent\n* If female, be either post-menopausal, surgically sterile, or agree to practice birth control during year of study and have negative serum Human Chorionic Gonadotropin (HCG) at screening/baseline\n\nExclusion Criteria:\n\n* Prior gastric or bariatric surgery or other alteration to upper gastrointestinal anatomy which would preclude safe or technical performance of ESG\n* Current or recent (last six months) gastric or duodenal ulceration\n* Esophageal or gastric varices\n* Significant motility disorder of the esophagus or stomach\n* Large hiatal hernia measuring \\>5 cm or \u2264 5 cm and associated with severe gastroesophageal reflux\n* Severe coagulopathy, hepatic insufficiency, or cirrhosis\n* Gastric mass\n* Presence of any other medical condition which precludes safe performance of elective endoscopy such as poor general health and/or history of severe hepatic, cardiac, or pulmonary disease\n* Serious or uncontrolled psychiatric illness which may compromise patient understanding of procedure or compliance with follow-up visits\n* Unwilling to participate in an established diet and behavior modification program, with routine follow-up\n* Ongoing corticosteroid use at a dose of \\>5 mg daily\n* Daily use of anti-inflammatory agents such as non-steroidal medications, or anticoagulants without medical supervision\n* Alcohol or drug addiction\n* Females who are pregnant, nursing, or planning pregnancy within the next year\n* Concomitant use of or unwillingness to avoid any use of weight loss medications, weight loss supplements, or weight loss herbal preparations\n* Has a condition or is in a situation which in the investigator's opinion may put the subject at significant risk or may interfere significantly with the subject's participation in the study",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "22 Years",
            "maximumAge": "69 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "ESG with IPAA Study Team",
                    "role": "CONTACT",
                    "phone": "507-538-8238",
                    "email": "DLRSTIPAAinfo@mayo.edu"
                },
                {
                    "name": "Abigail A Stromme",
                    "role": "CONTACT",
                    "phone": "507-538-8238",
                    "email": "stromme.abigail@mayo.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Amanda M Johnson, MD",
                    "affiliation": "Mayo Clinic",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic Minnesota",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Abigail A Stromme",
                            "role": "CONTACT",
                            "phone": "507-538-8238",
                            "email": "stromme.abigail@mayo.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Mayo Clinic Clinical Trials",
                    "url": "https://www.mayo.edu/research/clinical-trials"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003092",
                    "term": "Colitis"
                },
                {
                    "id": "D000003093",
                    "term": "Colitis, Ulcerative"
                },
                {
                    "id": "D000009765",
                    "term": "Obesity"
                },
                {
                    "id": "D000014456",
                    "term": "Ulcer"
                }
            ],
            "ancestors": [
                {
                    "id": "D000050177",
                    "term": "Overweight"
                },
                {
                    "id": "D000044343",
                    "term": "Overnutrition"
                },
                {
                    "id": "D000009748",
                    "term": "Nutrition Disorders"
                },
                {
                    "id": "D000001835",
                    "term": "Body Weight"
                },
                {
                    "id": "D000005759",
                    "term": "Gastroenteritis"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000003108",
                    "term": "Colonic Diseases"
                },
                {
                    "id": "D000007410",
                    "term": "Intestinal Diseases"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000015212",
                    "term": "Inflammatory Bowel Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M17206",
                    "name": "Ulcer",
                    "asFound": "Ulcerative",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12701",
                    "name": "Obesity",
                    "asFound": "Obesity",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6320",
                    "name": "Colitis",
                    "asFound": "Colitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6321",
                    "name": "Colitis, Ulcerative",
                    "asFound": "Ulcerative Colitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26186",
                    "name": "Overweight",
                    "relevance": "LOW"
                },
                {
                    "id": "M25307",
                    "name": "Overnutrition",
                    "relevance": "LOW"
                },
                {
                    "id": "M12684",
                    "name": "Nutrition Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5114",
                    "name": "Body Weight",
                    "relevance": "LOW"
                },
                {
                    "id": "M8875",
                    "name": "Gastroenteritis",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6336",
                    "name": "Colonic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10444",
                    "name": "Intestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17917",
                    "name": "Inflammatory Bowel Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                }
            ]
        }
    },
    "hasResults": false
}